e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD
Holly R. Keir, Alison Dicker, Mike Lonergan, Megan Crichton, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers
Source:
Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Holly R. Keir, Alison Dicker, Mike Lonergan, Megan Crichton, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers. Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD. Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Clinical phenotypes of exacerbation are associated with differences in microbial composition and diversity in COPD
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Clinical phenotypic differences between COPD and asthma in elderly patients
Source: Eur Respir J 2004; 24: Suppl. 48, 60s
Year: 2004
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 199s
Year: 2002
Relationship between the respiratory microbiome and systemic patterns in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Azurocidin-1: a marker of COPD severity and microbial dysbiosis
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Asthma and COPD: similarities and differences in pathogenesis
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Severity-related microbiome changes in COPD
Source: Annual Congress 2013 –COPD and infections
Year: 2013
A study of the relation of microbiological etiology with analytical and clinical parameters in exacerbation of COPD
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Different pattern of systemic and local inflammation in patients with exacerbation of COPD with different body composition
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Similarities and differences in inflammatory mechanisms of asthma and COPD
Source: Breathe 2011; 7: 229-238
Year: 2011
Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease
Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD
Year: 2011
Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Sources of origin of the oropharyngeal microbiota in patients with different phenotypes of COPD
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Differences of clinical characteristics and phenotype between biomass and tobacco related COPD
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept